Armour C L, Lazar N M, Schellenberg R R, Taylor S M, Chan N, Hogg J C, Paré P D
Am Rev Respir Dis. 1984 Jun;129(6):907-10. doi: 10.1164/arrd.1984.129.6.907.
To examine for a relationship between in vivo nonspecific bronchial reactivity to histamine and in vitro smooth muscle response to histamine, we performed inhalation dose-response curves prior to lung surgery in 12 patients and compared this with their bronchial smooth muscle response in vitro. In vivo reactivity was assessed by the provocative concentration of histamine resulting in a 20% fall in forced expiratory volume in one second (PC20), and in vitro reactivity was measured by the negative log of the molar concentration of histamine producing 50% maximal contraction (pD2) as well as maximal tension generated (Tmax). In addition, morphometric analysis was performed on the in vitro tissue to quantitate the amount of smooth muscle present. A wide range of in vivo responses was found in the 12 subjects (PC20-0.065 lead to 16). There was less in vitro variability and no correlation between PC20 and in vitro reactivity assessed by pD20 or Tmax or between PC20 and the percent of smooth muscle.
为了研究体内对组胺的非特异性支气管反应性与体外平滑肌对组胺的反应之间的关系,我们在12例患者肺手术前进行了吸入剂量反应曲线测定,并将其与他们体外支气管平滑肌反应进行比较。体内反应性通过导致一秒用力呼气量下降20%的组胺激发浓度(PC20)进行评估,体外反应性通过产生50%最大收缩的组胺摩尔浓度的负对数(pD2)以及产生的最大张力(Tmax)进行测量。此外,对体外组织进行形态计量分析以定量存在的平滑肌量。在12名受试者中发现了广泛的体内反应(PC20为0.065至16)。体外变异性较小,PC20与通过pD20或Tmax评估的体外反应性之间或PC20与平滑肌百分比之间均无相关性。